Accolade Inc Share Price Today (NASDAQ: ACCD)

Name: Accolade Inc Share Price (NASDAQ: ACCD) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Accolade Inc share price is $0 & ₹0.00 as on 3 Apr 2025 IST

▲

-7.02

(-100%)

Market is closed - opens 7 PM, 12 Jun 2025

The stock has been delisted from the stock exchange on 4 Apr 2025

View live Accolade Inc share price in Dollar and Rupees. Guide to invest in Accolade Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Accolade Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Accolade Inc (ACCD) Key Statistics

in dollars & INR

Previous Close	$7.02
Open	$7.03
Market Capitalization	$576.4M
Today's Volume	$4.6M
Revenue TTM	$446.7M
EBITDA	$-47.6M
Earnings Per Share (EPS)	$-2.28
Profit Margin	-40.36%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.23%

How to invest in Accolade Inc Stock (ACCD) from India?

It is very easy for Indian residents to invest directly in Accolade Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Accolade Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Accolade Inc or ACCD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Accolade Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Accolade Inc shares which would translate to null fractional shares of Accolade Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Accolade Inc, in just a few clicks!

Global Institutional Holdings in Accolade Inc

BlackRock Inc
7.59%
ARK Investment Management LLC
5.69%
Vanguard Group Inc
5.10%
Deerfield Management Co
4.24%
Millennium Management LLC
3.77%
D. E. Shaw & Co LP
2.78%

Analyst Recommendation on Accolade Inc

Rating

Trend

Buy

69%Buy

30%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Accolade Inc(by analysts ranked 0 to 5 stars)

ACCD Accolade Inc Financials in INR & Dollars

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Revenue	$414.3M	↑ 14.09%
Net Income	$-99.8M	↓ 78.29%
Net Profit Margin	-24.09%	↑ 102.49%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Revenue	$105.1M	↓ 1.22%
Net Income	$-121.3M	↑ 406.66%
Net Profit Margin	-115.42%	↓ 92.92%

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Profit	$192.1M	↑ 16.94%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Profit	$46.5M	↓ 5.97%

FY19

FY20

FY21

FY22

FY23

	FY23	Y/Y Change
Operating Cash Flow	$-40.7M	↓ 34.72%
Investing Cash Flow	$-7.2M	↓ 97.26%
Financing Cash Flow	$3.2M	↓ 98.77%

About Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Organization	Accolade Inc
Employees	2400
CEO	Mr. Rajeev Singh
Industry	Health Services

Management People of Accolade Inc

Name	Title
Mr. Rajeev Singh	Chairman of the Board & CEO
Mr. Robert Cavanaugh	President
Mr. Stephen H. Barnes CPA	CFO & Treasurer
Mr. Richard Eskew J.D.	Executive VP, General Counsel, CCO & Secretary
Ms. Kristen Bruzek	Senior Vice President of Operations
Mr. Colin McHugh	Chief Accounting Officer
Mr. Todd Friedman	Senior Vice President of Investor Relations
Ms. Kelsi McDonald Harris	Chief People Officer & Senior Vice President
Mr. Drew Garner	Executive Vice President of Engineering
Dr. Shantanu Nundy M.B.A., M.D.	Executive VP, Chief Health Officer & Member of the Medical Advisory Board

Important FAQs about investing in ACCD Stock from India :

Can Indians buy Accolade Inc shares?

Yes, Indians can invest in the Accolade Inc (ACCD) from India.

With INDmoney, you can buy Accolade Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Accolade Inc at zero transaction cost.

How can I buy Accolade Inc shares from India?

It is very easy to buy Accolade Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Accolade Inc (ACCD) be purchased?

Yes, you can buy fractional shares of Accolade Inc with INDmoney app.

What are the documents required to start investing in Accolade Inc stocks?

To start investing in Accolade Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Accolade Inc?

Today's market capitalisation of Accolade Inc ACCD is 576.4M

Who is the Chief Executive Officer (CEO) of Accolade Inc ?

Mr. Rajeev Singh is the current Chief Executive Officer (CEO) of Accolade Inc.

Discover More

Spdr S&p Telecom Etf
$107.53
-0.55%
Blackrock Future Health Etf
$24.84
+0.93%
Ngl Energy Partners Lp
$4.16
+3.48%
Box, Inc.
$35.92
-1.48%
Sonim Technologies Inc
$1.14
-3.39%
Ishares J.p. Morgan Em High
$38.45
+0.1%
Able View Global Inc
$1.23
+6.96%
Nuveen Global H-i Fd
$12.80
+0.16%
Spdr Ssga Us Eq Prem Inc Etf
$29.17
+0.34%

Explore all

	FY19	Y/Y Change
Revenue	$94.8M	↑ 23.41%
Net Income	$-56.5M	↓ 7.82%
Net Profit Margin	-59.59%	↑ 20.18%

	FY20	Y/Y Change
Revenue	$132.5M	↑ 39.76%
Net Income	$-51.4M	↓ 9.08%
Net Profit Margin	-38.76%	↑ 20.83%

	FY21	Y/Y Change
Revenue	$170.4M	↑ 28.57%
Net Income	$-50.7M	↓ 1.39%
Net Profit Margin	-29.73%	↑ 9.03%

	FY22	Y/Y Change
Revenue	$310.0M	↑ 81.98%
Net Income	$-123.1M	↑ 143.08%
Net Profit Margin	-39.71%	↓ 9.98%

	FY23	Y/Y Change
Revenue	$363.1M	↑ 17.13%
Net Income	$-459.7M	↑ 273.32%
Net Profit Margin	-126.58%	↓ 86.87%

	Q3 FY23	Q/Q Change
Revenue	$96.9M	↑ 3.9%
Net Income	$-32.8M	↓ 14.54%
Net Profit Margin	-33.89%	↑ 7.31%

	Q4 FY23	Q/Q Change
Revenue	$99.4M	↑ 2.59%
Net Income	$-21.1M	↓ 35.83%
Net Profit Margin	-21.2%	↑ 12.69%

	Q1 FY24	Q/Q Change
Revenue	$124.8M	↑ 25.62%
Net Income	$-7.5M	↓ 64.36%
Net Profit Margin	-6.01%	↑ 15.19%

	Q2 FY24	Q/Q Change
Revenue	$110.5M	↓ 11.51%
Net Income	$-27.6M	↑ 267.55%
Net Profit Margin	-24.98%	↓ 18.97%

	Q3 FY24	Q/Q Change
Revenue	$106.4M	↓ 3.72%
Net Income	$-23.9M	↓ 13.26%
Net Profit Margin	-22.5%	↑ 2.48%

	FY19	Y/Y Change
Operating Cash Flow	$-16.5M	↓ 56.78%
Investing Cash Flow	$-3.1M	↓ 56.41%
Financing Cash Flow	$48.8M	↑ 224.71%

	FY20	Y/Y Change
Operating Cash Flow	$-34.2M	↑ 106.96%
Investing Cash Flow	$-3.5M	↑ 12.92%
Financing Cash Flow	$28.2M	↓ 42.21%

	FY21	Y/Y Change
Operating Cash Flow	$-25.2M	↓ 26.32%
Investing Cash Flow	$-2.4M	↓ 31.18%
Financing Cash Flow	$428.4M	↑ 1417.91%

	FY22	Y/Y Change
Operating Cash Flow	$-62.4M	↑ 147.11%
Investing Cash Flow	$-263.6M	↑ 10779.61%
Financing Cash Flow	$257.9M	↓ 39.79%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-8.0M	↓ 58.32%
Investing Cash Flow	$-3.3M	↑ 0.0%
Financing Cash Flow	$641.0K	↓ 85.6%